Cooper Financial Group Buys 165 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Cooper Financial Group lifted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 8.0% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,239 shares of the healthcare conglomerate’s stock after acquiring an additional 165 shares during the period. Cooper Financial Group’s holdings in UnitedHealth Group were worth $1,108,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Richelieu Gestion SA purchased a new position in UnitedHealth Group during the 4th quarter worth $26,000. CGC Financial Services LLC grew its stake in UnitedHealth Group by 1,000.0% during the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after purchasing an additional 50 shares during the last quarter. True Wealth Design LLC purchased a new stake in UnitedHealth Group during the 4th quarter valued at about $31,000. LFA Lugano Financial Advisors SA grew its stake in UnitedHealth Group by 148.1% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock valued at $35,000 after purchasing an additional 40 shares during the last quarter. Finally, Transcendent Capital Group LLC purchased a new stake in UnitedHealth Group during the 4th quarter valued at about $40,000. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Trading Down 0.4 %

UNH opened at $482.59 on Monday. The firm has a market cap of $444.17 billion, a P/E ratio of 29.50, a P/E/G ratio of 1.41 and a beta of 0.58. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $554.70. The business has a fifty day simple moving average of $497.01 and a 200-day simple moving average of $503.62.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.63 by $0.28. The business had revenue of $99.80 billion for the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company’s revenue for the quarter was up 8.6% compared to the same quarter last year. During the same period last year, the firm earned $6.26 earnings per share. On average, equities analysts expect that UnitedHealth Group Incorporated will post 27.57 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 25th. Shareholders of record on Monday, June 17th will be paid a $2.10 dividend. The ex-dividend date is Monday, June 17th. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.88. This represents a $8.40 dividend on an annualized basis and a yield of 1.74%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 51.34%.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on UNH shares. Wells Fargo & Company decreased their price objective on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a report on Monday, April 8th. TD Cowen reduced their price target on UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating for the company in a report on Wednesday, April 10th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $591.00 price target on shares of UnitedHealth Group in a report on Wednesday, June 12th. Royal Bank of Canada reduced their price target on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating for the company in a report on Wednesday, April 17th. Finally, JPMorgan Chase & Co. increased their target price on UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a report on Thursday, May 30th. Three investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $579.74.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.